Aldeyra received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the resubmission of the NDA ...
Vevye offers a semiflourinated alkane formulation that targets dry eye inflammation by enhancing the penetration of ...
The topical ocular drug is an investigational new drug candidate that requires more well-controlled studies to establish ...
Frantz EyeCare’s highly-trained specialists strive to provide the most advanced treatment for healthy eyes in all phases of life.
The Company expects to have topline data from 2 trials assessing the effect of reproxalap on dry eye disease symptoms available in the second quarter of 2025.
Ophthalmologists say the soaring temperatures in Mumbai can cause a host of visual problems if residents are not careful ...
You may experience other symptoms with dry eye syndrome, such as ... health conditions or concerns that lead to glassy eyes. Treatments for Glassy Eyes The goal of treating glassy eyes is to ...
While dry eyes can be uncomfortable, it’s important to know that having dry eyes doesn’t directly cause blindness. But, without treatment, dry eyes can lead to complications that contribute to ...
The FDA rejected Aldeyra's resubmission for reproxalap, citing efficacy concerns. The company plans another trial and aims to ...
Aldeyra Therapeutics shares fell 73% to $1.42 in the regular session after it reported a Food and Drug Administration complete response letter for reproxalap for treatment of dry eye disease. The ...
Spring allergies can worsen dry eye syndrome, leading to irritation and discomfort. Learn how to manage symptoms and protect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results